These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 30428665)

  • 1. Recent Advances in Anti-cancer Protein/Peptide Delivery.
    Liu X; Wu F; Ji Y; Yin L
    Bioconjug Chem; 2019 Feb; 30(2):305-324. PubMed ID: 30428665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide and protein drug delivery to and into tumors: challenges and solutions.
    Torchilin VP; Lukyanov AN
    Drug Discov Today; 2003 Mar; 8(6):259-66. PubMed ID: 12623240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of Polymeric Carriers for Intracellular Peptide Delivery in Oncology Applications.
    Lv S; Sylvestre M; Prossnitz AN; Yang LF; Pun SH
    Chem Rev; 2021 Sep; 121(18):11653-11698. PubMed ID: 33566580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of peptide and protein nanotherapeutics by nanoencapsulation and nanobioconjugation.
    Yadav SC; Kumari A; Yadav R
    Peptides; 2011 Jan; 32(1):173-87. PubMed ID: 20934475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Nanotechnology in Delivery of Protein and Peptide Drugs.
    Patil S; Vhora I; Amrutiya J; Lalani R; Misra A
    Curr Pharm Des; 2015; 21(29):4155-73. PubMed ID: 26323432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Peptide-Decorated Targeted Drug Delivery: Exploring Therapeutic Potential and Nanocarrier Strategies.
    Buddhiraju HS; Yadav DN; Dey S; Eswar K; Padmakumar A; Rengan AK
    ACS Appl Bio Mater; 2024 Aug; 7(8):4879-4893. PubMed ID: 37996391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carrier-based strategies for targeting protein and peptide drugs to the lungs.
    Cryan SA
    AAPS J; 2005 Mar; 7(1):E20-41. PubMed ID: 16146340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
    Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
    Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
    Elzoghby AO; Hemasa AL; Freag MS
    J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Filamentous supramolecular peptide-drug conjugates as highly efficient drug delivery vehicles.
    Yang M; Xu D; Jiang L; Zhang L; Dustin D; Lund R; Liu L; Dong H
    Chem Commun (Camb); 2014 May; 50(37):4827-30. PubMed ID: 24682213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart Drug-Delivery Systems for Cancer Nanotherapy.
    Sanchez-Moreno P; Ortega-Vinuesa JL; Peula-Garcia JM; Marchal JA; Boulaiz H
    Curr Drug Targets; 2018 Feb; 19(4):339-359. PubMed ID: 27231107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unlocking nature's arsenal: Nanotechnology for targeted delivery of venom toxins in cancer therapy.
    Chary PS; Shaikh S; Rajana N; Bhavana V; Mehra NK
    Biomater Adv; 2024 Sep; 162():213903. PubMed ID: 38824828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
    Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
    Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-Installed Nanocarriers toward Precision Therapy.
    Mi P; Cabral H; Kataoka K
    Adv Mater; 2020 Apr; 32(13):e1902604. PubMed ID: 31353770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-targeted delivery systems based on peptides.
    Chatzisideri T; Leonidis G; Sarli V
    Future Med Chem; 2018 Sep; 10(18):2201-2226. PubMed ID: 30043641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.